Past and Present

A Review of Antenatal Corticosteroids and Recommendations for Late Preterm Birth Steroids

C. Luke Dixon, Gloria Too, George Saade, Cynthia Gyamfi-Bannerman

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Since 1972, the beneficial neonatal effects of antenatal corticosteroids (ACSs) have been repeatedly demonstrated in pregnancies at risk of preterm birth before 34 weeks' gestation. While ACS utilization before 34 weeks has been high since the 1990s, knowledge gaps regarding the risks and benefits of ACS continue to exist. Recent evidence has been published regarding the benefit of ACS in the late preterm period. This review addresses the evidence and knowledge gaps for ACS use before and after 34 weeks' gestation. We also provide recommendations for ACS use in the late preterm period.

Original languageEnglish (US)
Pages (from-to)1241-1250
Number of pages10
JournalAmerican Journal of Perinatology
Volume35
Issue number13
DOIs
StatePublished - May 23 2018

Fingerprint

Premature Birth
Adrenal Cortex Hormones
Steroids
Pregnancy

Keywords

  • antenatal corticosteroids
  • betamethasone
  • dexamethasone
  • fetal
  • late preterm steroids
  • maturity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Past and Present : A Review of Antenatal Corticosteroids and Recommendations for Late Preterm Birth Steroids. / Dixon, C. Luke; Too, Gloria; Saade, George; Gyamfi-Bannerman, Cynthia.

In: American Journal of Perinatology, Vol. 35, No. 13, 23.05.2018, p. 1241-1250.

Research output: Contribution to journalReview article

Dixon, C. Luke ; Too, Gloria ; Saade, George ; Gyamfi-Bannerman, Cynthia. / Past and Present : A Review of Antenatal Corticosteroids and Recommendations for Late Preterm Birth Steroids. In: American Journal of Perinatology. 2018 ; Vol. 35, No. 13. pp. 1241-1250.
@article{a3f9d6d296b545a88def2e9c0dafc737,
title = "Past and Present: A Review of Antenatal Corticosteroids and Recommendations for Late Preterm Birth Steroids",
abstract = "Since 1972, the beneficial neonatal effects of antenatal corticosteroids (ACSs) have been repeatedly demonstrated in pregnancies at risk of preterm birth before 34 weeks' gestation. While ACS utilization before 34 weeks has been high since the 1990s, knowledge gaps regarding the risks and benefits of ACS continue to exist. Recent evidence has been published regarding the benefit of ACS in the late preterm period. This review addresses the evidence and knowledge gaps for ACS use before and after 34 weeks' gestation. We also provide recommendations for ACS use in the late preterm period.",
keywords = "antenatal corticosteroids, betamethasone, dexamethasone, fetal, late preterm steroids, maturity",
author = "Dixon, {C. Luke} and Gloria Too and George Saade and Cynthia Gyamfi-Bannerman",
year = "2018",
month = "5",
day = "23",
doi = "10.1055/s-0038-1653944",
language = "English (US)",
volume = "35",
pages = "1241--1250",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "13",

}

TY - JOUR

T1 - Past and Present

T2 - A Review of Antenatal Corticosteroids and Recommendations for Late Preterm Birth Steroids

AU - Dixon, C. Luke

AU - Too, Gloria

AU - Saade, George

AU - Gyamfi-Bannerman, Cynthia

PY - 2018/5/23

Y1 - 2018/5/23

N2 - Since 1972, the beneficial neonatal effects of antenatal corticosteroids (ACSs) have been repeatedly demonstrated in pregnancies at risk of preterm birth before 34 weeks' gestation. While ACS utilization before 34 weeks has been high since the 1990s, knowledge gaps regarding the risks and benefits of ACS continue to exist. Recent evidence has been published regarding the benefit of ACS in the late preterm period. This review addresses the evidence and knowledge gaps for ACS use before and after 34 weeks' gestation. We also provide recommendations for ACS use in the late preterm period.

AB - Since 1972, the beneficial neonatal effects of antenatal corticosteroids (ACSs) have been repeatedly demonstrated in pregnancies at risk of preterm birth before 34 weeks' gestation. While ACS utilization before 34 weeks has been high since the 1990s, knowledge gaps regarding the risks and benefits of ACS continue to exist. Recent evidence has been published regarding the benefit of ACS in the late preterm period. This review addresses the evidence and knowledge gaps for ACS use before and after 34 weeks' gestation. We also provide recommendations for ACS use in the late preterm period.

KW - antenatal corticosteroids

KW - betamethasone

KW - dexamethasone

KW - fetal

KW - late preterm steroids

KW - maturity

UR - http://www.scopus.com/inward/record.url?scp=85047297639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047297639&partnerID=8YFLogxK

U2 - 10.1055/s-0038-1653944

DO - 10.1055/s-0038-1653944

M3 - Review article

VL - 35

SP - 1241

EP - 1250

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 13

ER -